Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating encouraging results in the management of type 2 diabetes. This synthetic peptide resembles the actions of naturally produced GLP-1, a https://zoevylj191591.azzablog.com/39532105/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes